Prospective Cardiac Ultrasound Imaging Study With Demonstrator (CARDIOKIT)
Primary Purpose
Ventricular Tachycardia
Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Cardiokit
Sponsored by
About this trial
This is an interventional other trial for Ventricular Tachycardia focused on measuring artificial intelligence, cardiac radioablation, echocardiography, motion monitoring, ventricular arrhythmia
Eligibility Criteria
Inclusion criteria: Patient with history of ventricular tachycardia Over 18 years old Ability and willingness to provide written informed consent Exclusion criteria: 1. Patient in arrhythmic storm
Sites / Locations
- IRCCS Policlinico San Matteo
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Device
Arm Description
The following procedure steps will take place: The study system is installed in the room before patient arrival The patient needs to fully undress the upper body before lying on the bed The 3 ECG electrodes are placed Ultrasound gel is applied on the ultrasound probe
Outcomes
Primary Outcome Measures
Image quality in terms of allowing a correct identification of the phase of the cardiac cycle by the prototype software.
The primary endpoint was defined as the percentage of patients able to obtain a positive result in a multi parametric score of image quality, consisting of:
Score = 1: average phase error per patient, defined as the difference between the phase of the cardiac cycle identified by the algorithm and the one evaluated by the ECG reference <0.1.
Score = 0: average phase error per patient ≥0.1.
For each patient, scoring was done for each imaging view (i.e., parasternal and apical). If the score was 2 (at least 1 point in A or B and 1 point in C or D) or greater for at least one of the imaging views, the outcome was considered as positive. The final result is the proportion of patients (in %) with a positive outcome, defined as the number of patients with a positive evaluation divided by the total number of patients x 100.
Image quality in terms of allowing a correct measurement of the heart displacement (mainly due to respiratory motion) by the prototype software.
The primary endpoint was defined as the percentage of patients able to obtain a positive result in a multi parametric score of image quality, consisting of:
Score = 1: maximum excursion calculated by the algorithm <30 mm with a total 3D error in the calculation of the displacement <3 mm.
Score = 0: either maximum excursion calculated by the algorithm ≥30 mm or total 3D error in the calculation of the displacement ≥3 mm (or both).
For each patient, scoring was done for each imaging view (i.e., parasternal and apical). If the score was 2 (at least 1 point in A or B and 1 point in C or D) or greater for at least one of the imaging views, the outcome was considered as positive. The final result is the proportion of patients (in %) with a positive outcome, defined as the number of patients with a positive evaluation divided by the total number of patients x 100.
Image quality in terms of the ability to distinguish typical cardiac structures, as assessed visually by the clinical operator.
The primary endpoint was defined as the percentage of patients able to obtain a positive result in a multi parametric score of image quality, consisting of:
Score = 1: ability to identify visually by an experienced operator in the acquired image at least one of the following structures: left ventricular free wall, interventricular septum, mitral valve, or aortic valve.
Score = 0: inability to identify at least one of these structures.
For each patient, scoring was done for each imaging view (i.e., parasternal and apical). If the score was 2 (at least 1 point in A or B and 1 point in C or D) or greater for at least one of the imaging views, the outcome was considered as positive. The final result is the proportion of patients (in %) with a positive outcome, defined as the number of patients with a positive evaluation divided by the total number of patients x 100.
Image quality in terms of the stability of the image throughout the respiration cycle, as assessed visually by the clinical operator.
The primary endpoint was defined as the percentage of patients able to obtain a positive result in a multi parametric score of image quality, consisting of:
Score = 1: persistence of cardiac structures within the echocardiographic image during respiratory motion.
Score = 0: disappearance of cardiac structures from the echocardiographic image during respiratory motion.
For each patient, scoring was done for each imaging view (i.e., parasternal and apical). If the score was 2 (at least 1 point in A or B and 1 point in C or D) or greater for at least one of the imaging views, the outcome was considered as positive. The final result is the proportion of patients (in %) with a positive outcome, defined as the number of patients with a positive evaluation divided by the total number of patients x 100.
Secondary Outcome Measures
Full Information
NCT ID
NCT05850741
First Posted
April 29, 2023
Last Updated
May 12, 2023
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
1. Study Identification
Unique Protocol Identification Number
NCT05850741
Brief Title
Prospective Cardiac Ultrasound Imaging Study With Demonstrator
Acronym
CARDIOKIT
Official Title
Prospective Cardiac Ultrasound Imaging Study With Demonstrator
Study Type
Interventional
2. Study Status
Record Verification Date
May 2023
Overall Recruitment Status
Completed
Study Start Date
June 4, 2021 (Actual)
Primary Completion Date
July 5, 2021 (Actual)
Study Completion Date
February 3, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The Prospective Cardiac Ultrasound Imaging Study is a single center, single arm, feasibility study. The study aims at collecting cardiac ultrasound data from patients diagnosed with ventricular tachycardia, during rest and short breath hold sequences. This study is part of the engineering studies linked to the CardioKit-Minimum Viable Product project. The CardioKit prototype used in the study can monitor cyclical heart-beat motion, cyclical respiratory motion and non-cyclical heart position changes while the patient is lying in supine position.
Detailed Description
The research will analyse the ultrasound image data quality, especially investigating the ability of the prototype system to automatically and correctly interpret ultrasound images and artifact issues which may arise from age, body composition, mechanical valves, leads from implanted devices, or other implants. The study will establish if it is appropriate to develop a new medical device supporting automated cardiac ultrasound image interpretation during non-invasive cardiac procedures, i.e. ventricular tachycardia stereotactic radioablation. This early research protocol did collect data from 24 adult patients. The data were not used for diagnostic nor treatment purposes and the protocol's procedure duration was limited to one hour, hence the research was considered of very limited risk for the participants. The research will provide a Proof-of-Concept for a Medical Device to benefit patients with ventricular tachycardia and other cardiac pathologies in the future.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ventricular Tachycardia
Keywords
artificial intelligence, cardiac radioablation, echocardiography, motion monitoring, ventricular arrhythmia
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
24 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Device
Arm Type
Experimental
Arm Description
The following procedure steps will take place:
The study system is installed in the room before patient arrival
The patient needs to fully undress the upper body before lying on the bed
The 3 ECG electrodes are placed
Ultrasound gel is applied on the ultrasound probe
Intervention Type
Device
Intervention Name(s)
Cardiokit
Intervention Description
The CardioKit prototype used in the study can monitor cyclical heart-beat motion, cyclical respiratory motion and non-cyclical heart position changes while the patient is lying in supine position.
Primary Outcome Measure Information:
Title
Image quality in terms of allowing a correct identification of the phase of the cardiac cycle by the prototype software.
Description
The primary endpoint was defined as the percentage of patients able to obtain a positive result in a multi parametric score of image quality, consisting of:
Score = 1: average phase error per patient, defined as the difference between the phase of the cardiac cycle identified by the algorithm and the one evaluated by the ECG reference <0.1.
Score = 0: average phase error per patient ≥0.1.
For each patient, scoring was done for each imaging view (i.e., parasternal and apical). If the score was 2 (at least 1 point in A or B and 1 point in C or D) or greater for at least one of the imaging views, the outcome was considered as positive. The final result is the proportion of patients (in %) with a positive outcome, defined as the number of patients with a positive evaluation divided by the total number of patients x 100.
Time Frame
Baseline
Title
Image quality in terms of allowing a correct measurement of the heart displacement (mainly due to respiratory motion) by the prototype software.
Description
The primary endpoint was defined as the percentage of patients able to obtain a positive result in a multi parametric score of image quality, consisting of:
Score = 1: maximum excursion calculated by the algorithm <30 mm with a total 3D error in the calculation of the displacement <3 mm.
Score = 0: either maximum excursion calculated by the algorithm ≥30 mm or total 3D error in the calculation of the displacement ≥3 mm (or both).
For each patient, scoring was done for each imaging view (i.e., parasternal and apical). If the score was 2 (at least 1 point in A or B and 1 point in C or D) or greater for at least one of the imaging views, the outcome was considered as positive. The final result is the proportion of patients (in %) with a positive outcome, defined as the number of patients with a positive evaluation divided by the total number of patients x 100.
Time Frame
Baseline
Title
Image quality in terms of the ability to distinguish typical cardiac structures, as assessed visually by the clinical operator.
Description
The primary endpoint was defined as the percentage of patients able to obtain a positive result in a multi parametric score of image quality, consisting of:
Score = 1: ability to identify visually by an experienced operator in the acquired image at least one of the following structures: left ventricular free wall, interventricular septum, mitral valve, or aortic valve.
Score = 0: inability to identify at least one of these structures.
For each patient, scoring was done for each imaging view (i.e., parasternal and apical). If the score was 2 (at least 1 point in A or B and 1 point in C or D) or greater for at least one of the imaging views, the outcome was considered as positive. The final result is the proportion of patients (in %) with a positive outcome, defined as the number of patients with a positive evaluation divided by the total number of patients x 100.
Time Frame
Baseline
Title
Image quality in terms of the stability of the image throughout the respiration cycle, as assessed visually by the clinical operator.
Description
The primary endpoint was defined as the percentage of patients able to obtain a positive result in a multi parametric score of image quality, consisting of:
Score = 1: persistence of cardiac structures within the echocardiographic image during respiratory motion.
Score = 0: disappearance of cardiac structures from the echocardiographic image during respiratory motion.
For each patient, scoring was done for each imaging view (i.e., parasternal and apical). If the score was 2 (at least 1 point in A or B and 1 point in C or D) or greater for at least one of the imaging views, the outcome was considered as positive. The final result is the proportion of patients (in %) with a positive outcome, defined as the number of patients with a positive evaluation divided by the total number of patients x 100.
Time Frame
Baseline
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria:
Patient with history of ventricular tachycardia
Over 18 years old
Ability and willingness to provide written informed consent
Exclusion criteria:
1. Patient in arrhythmic storm
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Roberto Rordorf, md
Organizational Affiliation
Fondazione IRCCS Policlinico San Matteo di Pavia
Official's Role
Principal Investigator
Facility Information:
Facility Name
IRCCS Policlinico San Matteo
City
Pavia
ZIP/Postal Code
27100
Country
Italy
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Prospective Cardiac Ultrasound Imaging Study With Demonstrator
We'll reach out to this number within 24 hrs